JT
NRIX icon

Jupiter Topco’s Nurix Therapeutics NRIX Stock Holding History

Jupiter Topco’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$594K Buy
+24,500
New +$417K ﹤0.01% 2019

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
General Atlantic New York $2.91B AUM 24.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jupiter Topco's NRIX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 24,500 shares worth $594K. The stake represents ﹤0.01% of the portfolio and ranks #2019 among its holdings.

194 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Jupiter Topco held 24,500 shares of Nurix Therapeutics worth $594K as of Q2 2026.
  • Nurix Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Nurix Therapeutics made up ﹤0.01% of Jupiter Topco's portfolio in Q2 2026, its #2019 holding.
  • 194 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.